BRCA2 and neoplasm: Although most BRCA1/2 carriers developed later-onset esophagogastric cancer, 28.6% of patients had early-onset disease, including a 35-year-old BRCA2 carrier whose tumor also carried a second somatic BRCA2 variant, suggesting that the germline BRCA2 variant contributed to carcinogenesis.